Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor alpha antagonists and disease-modifying antirheumatic drugs
| Autor: | Kenneth G. Saag, Deborah Shatin, Jeffrey R. Curtis, Jeroan J. Allison, Judith M. Kramer, M. Miles Braun, Carolyn K. Martin, Nivedita M. Patkar |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
Adult
Male Databases Factual Opportunistic infection Immunology Arthritis Disease Opportunistic Infections Bioinformatics Receptors Tumor Necrosis Factor Etanercept Arthritis Rheumatoid Rheumatology Crohn Disease Predictive Value of Tests medicine Immunology and Allergy Humans Pharmacology (medical) Adverse effect Insurance Health business.industry Tumor Necrosis Factor-alpha Incidence Antibodies Monoclonal Middle Aged medicine.disease Infliximab Antirheumatic Agents Immunoglobulin G Tumor necrosis factor alpha Female Antirheumatic drugs business medicine.drug |
| Zdroj: | Arthritis and rheumatism. 57(2) |
| ISSN: | 0004-3591 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text